Scholars International Webinar on

Cancer Research and Therapeutics

THEME: "Advancements in Cancer Research and Therapeutics"

img2 14-16 Nov 2022
img2 Online | Virtual

ABOUT CANCER RESEARCH WEBINAR 2022

It is my great honor and pleasure as an Organizing Committee Member and Speaker to invite you to join with a contribution to the 3rd Edition of Scholars international Webinar on Cancer Research and therapeutics (Cancer Research Webinar 2022) during November 14-16, 2022. The Webinar will include Keynote speeches and Invited speeches which will be given by Distinguished Scholars and Experts from academic institutions and industry, and oral presentation by delegate and poster presentations by young junior participants. Devoted to the rapid development of Cancer Research and Therapeutics, the conference will bring together distinguished experts, researchers, scientist, scholars, and young students from different cultures and different countries, providing them with the opportunity to report, share, and discuss scientific questions, achievements, in these fields.

 

This Webinar will provide excellent opportunity to meet distinguished scholars and experts and to exchange new ideas and application experiences, to establish research relations and collaborations for future research and projects.

As an Organizing Committee Member, I believe that Cancer Research Webinar 2021 will be a platform to discuss a broad range of topics from Cancer Research to Diagnosis including Cancer Therapy for the academicians, scholars, investigators and associated experts in the field of Oncology Research from all over the globe for sharing familiarity, exchanging ideas, collaborate and to showcase their research results about all features of their work and application experiences, to establish research or business relations.

I am pleased to invite prospective authors to submit their original contributions to this important event, where you are sure to have a meaningful experience with scholars and experts from different cultures and different countries.